Medical Gas Research is a prominent academic journal dedicated to the field of anesthesiology and pain medicine, published by Wolters Kluwer Medknow Publications. With an ISSN of 2045-9912, this journal operates under a robust open access model, facilitating the wide dissemination of research findings across a global audience. Based in India, Medical Gas Research aims to present innovative studies and reviews that explore the therapeutic applications of medical gases, their mechanisms of action, and their impact on various neurological conditions. The journal has an admirable positioning within academic rankings, holding a Q2 classification in Anesthesiology and Pain Medicine and a Q3 designation in Neuroscience (miscellaneous) for 2023, reflecting its significant influence in these domains. Moreover, it ranks #35 out of 136 in the field of Anesthesiology, highlighting its contribution to advancing this vital area of medicine. Overall, the journal serves as an essential resource for researchers, professionals, and students aiming to stay abreast of the latest advancements and interdisciplinary approaches within the medical gas research landscape.

Clinical Infectious Diseases, published by Oxford University Press Inc, is a premier journal in the fields of infectious diseases and microbiology, distinguished by its esteemed Q1 ranking in both categories as of 2023. Since its inception, the journal has served as a vital platform for disseminating cutting-edge research and significant advancements in the diagnosis, treatment, and prevention of infectious diseases. With a broad scope encompassing clinical trials, epidemiological studies, and public health research, it targets a diverse readership, including researchers, healthcare professionals, and students. The journal's robust reputation is underscored by its impactful contributions to scientific understanding, making it a critical resource for those striving to combat infectious diseases globally. Clinical Infectious Diseases is not open access but offers various subscription options, ensuring comprehensive access to its high-quality content. With a historical continuity from 1985 to present, the journal remains at the forefront of medical research, paving the way for future innovations in the field.

Current Drug Safety is a distinguished peer-reviewed journal published by Bentham Science Publishers, focusing on the critical intersection of pharmacology and toxicology. With an ISSN of 1574-8863 and an E-ISSN of 2212-3911, this journal serves as a platform for the latest research and advances in drug safety, highlighting the importance of pharmacological assessments and toxicity evaluations in therapeutic development and public health. Reaching a broad international audience from its base in the United Arab Emirates, Current Drug Safety offers an invaluable resource for researchers, professionals, and students interested in the dynamic fields of drug research and safety management. Despite a current Q3 categorization in multiple pharmacology and toxicology quartiles for 2023, the journal continues to strive for excellence in the scholarly community, reflecting its commitment to disseminating high-quality research. While not operating under an open access model, articles can be accessed through institutional subscriptions and other platforms, ensuring valuable insights into drug safety are available to those who need it most.

JOURNAL OF AVIAN MEDICINE AND SURGERY, published by the Association of Avian Veterinarians, serves as an essential resource for professionals and researchers in the field of avian veterinary medicine. Established in 1996, the journal has consistently contributed to the understanding and advancement of medical and surgical practices in avian species, showcasing innovative research and comprehensive reviews that address the unique health challenges faced by birds. With an ISSN of 1082-6742 and an E-ISSN of 1938-2871, this journal is indexed in Scopus, ranking 13th out of 20 in the Small Animals category, placing it within the 37th percentile and exemplifying its impact in the veterinary community. Although not an Open Access journal, it is vital for advancing knowledge and improving veterinary care for avian clients. Its commitment to excellence is reflected in its designation within the Q3 quartile in both miscellaneous medicine and small animals, indicating its growing influence and relevance in the veterinary literature. The journal encourages contributions that enhance the understanding of avian health, providing a platform for ideas that will drive progress in this niche field.

Flugmedizin Tropenmedizin Reisemedizin is a prominent journal published by GEORG THIEME VERLAG KG, specializing in the interdisciplinary fields of aviation medicine, tropical medicine, and travel health. With its ISSN 1864-4538 and E-ISSN 1864-175X, this journal serves as a vital resource for healthcare professionals, researchers, and students who are dedicated to enhancing health and safety in the areas influenced by air travel and tropical environments. Although not currently open access, it boasts a rich repository of studies and reviews that address the latest findings and practices in these critical fields. The journal’s commitment to advancing knowledge and clinical practices makes it an essential read for those involved in travel medicine and public health initiatives, fostering an informed community of practitioners ready to tackle emerging global health challenges.

Aerospace Medicine and Human Performance is an influential journal published by the Aerospace Medical Association, serving as a vital resource for researchers and professionals dedicated to the study of human performance within the realms of aerospace environments. With an ISSN of 2375-6314 and an E-ISSN of 2375-6322, this journal has garnered attention since its inception in 2015 and is dedicated to the dissemination of innovative research, reviews, and case studies that address the complexities of human factors in aviation and space travel. Despite being classified in the Q4 quartile in both Medicine (Miscellaneous) and Public Health, Environmental and Occupational Health categories as of 2023, and its respective Scopus rankings showing opportunities for growth, the journal plays a critical role in bridging gaps in knowledge and promoting advancements in medical practices and safety standards in aerospace contexts. The journal operates under an Open Access model, ensuring that valuable research is readily available to a diverse audience. As it converges into the years up to 2024, it remains committed to enhancing the collaboration and communication within the aerospace medical community.

MEDICAL LETTER ON DRUGS AND THERAPEUTICS is a pivotal resource for professionals in the fields of medicine and pharmacology, published by MED LETTER INC. Since its inception in 1965, this journal has been committed to elucidating the complexities of drug therapy and clinical therapeutics, offering readers evidence-based insights and critical evaluations of the latest medications and treatment protocols. With a quarterly ranking reflecting its stature—Q4 in Medicine (Miscellaneous) and Q3 in both Pharmacology and Pharmacology (Medical)—the journal maintains a specific niche ensuring readers are equipped with updated information that continues to influence healthcare practices. Although it does not operate under an open access model, the journal is accessible to institutions and professionals eager to stay at the forefront of medicinal advancements. The importance of this journal lies in its dedication to enhancing pharmacological knowledge, thus catering to the needs of researchers, healthcare providers, and students alike, making it an essential addition to the literature in therapeutic drug interventions.

Undersea and Hyperbaric Medicine is a pivotal journal published by the Undersea & Hyperbaric Medical Society Inc., focusing on the advanced field of undersea and hyperbaric medical research. It has served the scientific community since its inception in 1993, and is recognized for its commitment to disseminating peer-reviewed articles that address both the clinical and scientific aspects of hyperbaric medicine and related disciplines. The journal is indexed in various databases and classified in key quartiles, ranking Q3 in Medicine (miscellaneous) and Q4 in Physiology (medical) as of 2023, making it an essential resource for professionals engaged in these specialized areas. Although the journal does not currently offer open access, its implications and contributions to the fields of pulmonary and respiratory medicine and physiology are substantial, with a Scopus rank indicating its relevance despite some competitive challenges. This publication serves as a vital platform for researchers, allows for the exploration of novel therapies, and promotes the dissemination of knowledge critical for advancements in medical practice related to undersea and hyperbaric environments.

PESQUISA VETERINARIA BRASILEIRA is a premier scholarly journal that serves as a vital platform for disseminating high-quality research in the field of veterinary sciences. Published by REVISTA PESQUISA VETERINARIA BRASILEIRA, this Open Access journal has been a beacon of knowledge since 1997, allowing global access to its valuable content and fostering collaboration among researchers, professionals, and students. With an ISSN of 0100-736X and an E-ISSN of 1678-5150, it stands out for its commitment to enhancing the understanding of veterinary practices, animal health, and public health implications in the context of Brazil and beyond. As of 2023, it holds a Q3 category in veterinary miscellaneous and ranks at the 43rd percentile according to Scopus, reflecting its growing influence and contribution to the veterinary community. Based in Seropédica, Rio de Janeiro, this journal publishes research covering a wide range of topics, aiming to facilitate knowledge exchange and drive innovation within the field. Join the conversation and contribute to the advancement of veterinary science through your submissions and readership.

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, published by MARY ANN LIEBERT, INC, stands as a premier academic journal dedicated to advancing the field of pediatric psychopharmacology. With a rich history of publication spanning from 1990 to 2024, this journal presents cutting-edge research that informs clinical practices and policy decisions impacting the mental health of children and adolescents. Ranked in the Q2 category for both Pediatrics, Perinatology and Child Health and Pharmacology (medical) as of 2023, it reflects its critical contribution to these fields, along with a respectable Q3 status in Psychiatry and Mental Health. Researchers and practitioners benefit from the journal's rigorous peer-reviewed articles, which delve into the efficacy, safety, and ethical implications of pharmacological treatments tailored for young populations. Although the journal does not currently offer Open Access, it remains a vital resource for anyone engaged in child and adolescent health research and treatment strategies. Its commitment to fostering dialogue and innovation in psychopharmacology ensures its pivotal role in shaping future standards and practices in this essential area of medical science.